TAM
Tocqueville Asset Management Portfolio holdings
AUM
$6.55B
1-Year Return
21.88%
This Quarter Return
-16.25%
1 Year Return
+21.88%
3 Year Return
+89.23%
5 Year Return
+153.22%
10 Year Return
+366.25%
AUM
$4.02B
AUM Growth
-$2.77B
(-41%)
Cap. Flow
-$1.61B
Cap. Flow
% of AUM
-40.05%
Top 10 Holdings %
Top 10 Hldgs %
24.65%
Holding
792
New
64
Increased
189
Reduced
285
Closed
153
Top Buys
| 1 |
eBay
EBAY
|
$23.8M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$17.9M |
| 3 |
Honeywell
HON
|
$17.2M |
| 4 |
Amazon
AMZN
|
$15.1M |
| 5 |
Cisco
CSCO
|
$13.7M |
Top Sells
| 1 |
Franco-Nevada
FNV
|
$82.2M |
| 2 |
B2Gold
BTG
|
$72.2M |
| 3 |
Wheaton Precious Metals
WPM
|
$67.8M |
| 4 |
NovaGold Resources
NG
|
$66.7M |
| 5 |
AngloGold Ashanti
AU
|
$64.8M |
Sector Composition
| 1 | Technology | 18.15% |
| 2 | Consumer Discretionary | 15.07% |
| 3 | Healthcare | 12.31% |
| 4 | Industrials | 8.84% |
| 5 | Communication Services | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RCM
376
DELISTED
R1 RCM Inc. Common Stock
RCM
| $636K | 0.02% |
+70,000
| New | +$636K |
|
377
Ross Stores
ROST
$49.4B
| $629K | 0.02% |
7,237
| – | – |
|
378
Coherent
COHR
$15.2B
| $623K | 0.02% |
21,865
+350
| +2% | +$9.97K |
|
379
BCE
BCE
$23.1B
| $621K | 0.02% |
15,200
-800
| -5% | -$32.7K |
|
|
AGN
380
DELISTED
Allergan plc
AGN
| $621K | 0.02% |
3,509
-80,478
| -96% | -$14.2M |
|
|
ABMD
381
DELISTED
Abiomed Inc
ABMD
| $619K | 0.02% |
+4,265
| New | +$619K |
|
382
Blue Bird Corp
BLBD
$1.87B
| $603K | 0.02% |
55,131
-1,805
| -3% | -$19.7K |
|
383
iShares MSCI USA Min Vol Factor ETF
USMV
$23.4B
| $594K | 0.01% |
11,006
-8,513
| -44% | -$459K |
|
384
SPDR S&P Dividend ETF
SDY
$20.5B
| $590K | 0.01% |
7,389
-350
| -5% | -$27.9K |
|
|
CGAU
385
Centerra Gold
CGAU
$1.76B
| $588K | 0.01% |
+100,000
| New | +$588K |
|
386
Northrop Grumman
NOC
$83.2B
| $584K | 0.01% |
1,930
-4,809
| -71% | -$1.46M |
|
387
Dycom Industries
DY
$7.19B
| $580K | 0.01% |
22,620
-14,050
| -38% | -$360K |
|
388
MSCI
MSCI
$42.9B
| $578K | 0.01% |
2,000
| – | – |
|
|
RETA
389
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $577K | 0.01% |
4,000
| – | – |
|
390
Acadia Pharmaceuticals
ACAD
$4.26B
| $576K | 0.01% |
13,625
| – | – |
|
391
AZZ Inc
AZZ
$3.51B
| $572K | 0.01% |
20,355
-615
| -3% | -$17.3K |
|
392
L3Harris
LHX
$51B
| $564K | 0.01% |
3,130
-1,130
| -27% | -$204K |
|
393
TransUnion
TRU
$17.5B
| $563K | 0.01% |
8,500
| – | – |
|
|
DFS
394
DELISTED
Discover Financial Services
DFS
| $555K | 0.01% |
15,559
-20
| -0.1% | -$713 |
|
395
Vanguard Value ETF
VTV
$143B
| $543K | 0.01% |
6,096
+1,604
| +36% | +$143K |
|
396
Omnicom Group
OMC
$15.4B
| $541K | 0.01% |
9,849
-2,754
| -22% | -$151K |
|
397
Pool Corp
POOL
$12.4B
| $541K | 0.01% |
2,750
+750
| +38% | +$148K |
|
398
Ironwood Pharmaceuticals
IRWD
$188M
| $540K | 0.01% |
53,531
| – | – |
|
399
iShares Russell 2500 ETF
SMMD
$1.64B
| $540K | 0.01% |
16,055
+7,450
| +87% | +$251K |
|
400
Vertex Pharmaceuticals
VRTX
$102B
| $540K | 0.01% |
2,270
+725
| +47% | +$172K |
|